Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression

Abstract Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are clonal hematopoietic stem cell disorders with a poor prognosis, especially for elderly patients. Increasing evidence suggests that alterations in the non-hematopoietic microenvironment (bone marrow niche) can contribute to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marie-Theresa Weickert, Judith S. Hecker, Michèle C. Buck, Christina Schreck, Jennifer Rivière, Matthias Schiemann, Katharina Schallmoser, Florian Bassermann, Dirk Strunk, Robert A. J. Oostendorp, Katharina S. Götze
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c226cd0ba70e465cbd553e5471ceb2e7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c226cd0ba70e465cbd553e5471ceb2e7
record_format dspace
spelling oai:doaj.org-article:c226cd0ba70e465cbd553e5471ceb2e72021-12-02T16:30:37ZBone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression10.1038/s41598-021-85122-82045-2322https://doaj.org/article/c226cd0ba70e465cbd553e5471ceb2e72021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85122-8https://doaj.org/toc/2045-2322Abstract Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are clonal hematopoietic stem cell disorders with a poor prognosis, especially for elderly patients. Increasing evidence suggests that alterations in the non-hematopoietic microenvironment (bone marrow niche) can contribute to or initiate malignant transformation and promote disease progression. One of the key components of the bone marrow (BM) niche are BM stromal cells (BMSC) that give rise to osteoblasts and adipocytes. It has been shown that the balance between these two cell types plays an important role in the regulation of hematopoiesis. However, data on the number of BMSC and the regulation of their differentiation balance in the context of hematopoietic malignancies is scarce. We established a stringent flow cytometric protocol for the prospective isolation of a CD73+ CD105+ CD271+ BMSC subpopulation from uncultivated cryopreserved BM of MDS and AML patients as well as age-matched healthy donors. BMSC from MDS and AML patients showed a strongly reduced frequency of CFU-F (colony forming unit-fibroblast). Moreover, we found an altered phenotype and reduced replating efficiency upon passaging of BMSC from MDS and AML samples. Expression analysis of genes involved in adipo- and osteogenic differentiation as well as Wnt- and Notch-signalling pathways showed significantly reduced levels of DLK1, an early adipogenic cell fate inhibitor in MDS and AML BMSC. Matching this observation, functional analysis showed significantly increased in vitro adipogenic differentiation potential in BMSC from MDS and AML patients. Overall, our data show BMSC with a reduced CFU-F capacity, and an altered molecular and functional profile from MDS and AML patients in culture, indicating an increased adipogenic lineage potential that is likely to provide a disease-promoting microenvironment.Marie-Theresa WeickertJudith S. HeckerMichèle C. BuckChristina SchreckJennifer RivièreMatthias SchiemannKatharina SchallmoserFlorian BassermannDirk StrunkRobert A. J. OostendorpKatharina S. GötzeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marie-Theresa Weickert
Judith S. Hecker
Michèle C. Buck
Christina Schreck
Jennifer Rivière
Matthias Schiemann
Katharina Schallmoser
Florian Bassermann
Dirk Strunk
Robert A. J. Oostendorp
Katharina S. Götze
Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression
description Abstract Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are clonal hematopoietic stem cell disorders with a poor prognosis, especially for elderly patients. Increasing evidence suggests that alterations in the non-hematopoietic microenvironment (bone marrow niche) can contribute to or initiate malignant transformation and promote disease progression. One of the key components of the bone marrow (BM) niche are BM stromal cells (BMSC) that give rise to osteoblasts and adipocytes. It has been shown that the balance between these two cell types plays an important role in the regulation of hematopoiesis. However, data on the number of BMSC and the regulation of their differentiation balance in the context of hematopoietic malignancies is scarce. We established a stringent flow cytometric protocol for the prospective isolation of a CD73+ CD105+ CD271+ BMSC subpopulation from uncultivated cryopreserved BM of MDS and AML patients as well as age-matched healthy donors. BMSC from MDS and AML patients showed a strongly reduced frequency of CFU-F (colony forming unit-fibroblast). Moreover, we found an altered phenotype and reduced replating efficiency upon passaging of BMSC from MDS and AML samples. Expression analysis of genes involved in adipo- and osteogenic differentiation as well as Wnt- and Notch-signalling pathways showed significantly reduced levels of DLK1, an early adipogenic cell fate inhibitor in MDS and AML BMSC. Matching this observation, functional analysis showed significantly increased in vitro adipogenic differentiation potential in BMSC from MDS and AML patients. Overall, our data show BMSC with a reduced CFU-F capacity, and an altered molecular and functional profile from MDS and AML patients in culture, indicating an increased adipogenic lineage potential that is likely to provide a disease-promoting microenvironment.
format article
author Marie-Theresa Weickert
Judith S. Hecker
Michèle C. Buck
Christina Schreck
Jennifer Rivière
Matthias Schiemann
Katharina Schallmoser
Florian Bassermann
Dirk Strunk
Robert A. J. Oostendorp
Katharina S. Götze
author_facet Marie-Theresa Weickert
Judith S. Hecker
Michèle C. Buck
Christina Schreck
Jennifer Rivière
Matthias Schiemann
Katharina Schallmoser
Florian Bassermann
Dirk Strunk
Robert A. J. Oostendorp
Katharina S. Götze
author_sort Marie-Theresa Weickert
title Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression
title_short Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression
title_full Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression
title_fullStr Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression
title_full_unstemmed Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression
title_sort bone marrow stromal cells from mds and aml patients show increased adipogenic potential with reduced delta-like-1 expression
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/c226cd0ba70e465cbd553e5471ceb2e7
work_keys_str_mv AT marietheresaweickert bonemarrowstromalcellsfrommdsandamlpatientsshowincreasedadipogenicpotentialwithreduceddeltalike1expression
AT judithshecker bonemarrowstromalcellsfrommdsandamlpatientsshowincreasedadipogenicpotentialwithreduceddeltalike1expression
AT michelecbuck bonemarrowstromalcellsfrommdsandamlpatientsshowincreasedadipogenicpotentialwithreduceddeltalike1expression
AT christinaschreck bonemarrowstromalcellsfrommdsandamlpatientsshowincreasedadipogenicpotentialwithreduceddeltalike1expression
AT jenniferriviere bonemarrowstromalcellsfrommdsandamlpatientsshowincreasedadipogenicpotentialwithreduceddeltalike1expression
AT matthiasschiemann bonemarrowstromalcellsfrommdsandamlpatientsshowincreasedadipogenicpotentialwithreduceddeltalike1expression
AT katharinaschallmoser bonemarrowstromalcellsfrommdsandamlpatientsshowincreasedadipogenicpotentialwithreduceddeltalike1expression
AT florianbassermann bonemarrowstromalcellsfrommdsandamlpatientsshowincreasedadipogenicpotentialwithreduceddeltalike1expression
AT dirkstrunk bonemarrowstromalcellsfrommdsandamlpatientsshowincreasedadipogenicpotentialwithreduceddeltalike1expression
AT robertajoostendorp bonemarrowstromalcellsfrommdsandamlpatientsshowincreasedadipogenicpotentialwithreduceddeltalike1expression
AT katharinasgotze bonemarrowstromalcellsfrommdsandamlpatientsshowincreasedadipogenicpotentialwithreduceddeltalike1expression
_version_ 1718383956941864960